Now, it has decided to publish a special report on two of GSK's COPD therapies – Breo Ellipta (fluticasone furoate and vilanterol) and Trelegy Ellipta (fluticasone furoate, umeclidinium ...

In conclusion, COPD management requires a transformative approach that goes beyond traditional pharmaceutical solutions. By ...

Dr Lutz Beckert, Professor of Medicine at the University of Otago and a respiratory specialist with Te Whatu Ora Canterbury says the new COPD Clinical Care Standard, which was launched last month by ...

Amanda Southcombe, GSK NZ General Manager, says funding for Trelegy Ellipta was recently announced, a single inhaler triple-therapy to treat the disease, which will see around 15,000 Kiwis ...

Amanda Southcombe, GSK NZ General Manager, says funding for Trelegy Ellipta was recently announced, a single inhaler triple-therapy to treat the disease, which will see around 15,000 Kiwis suffering ...

We need better utilisation of funding, more clinicians, and greater access to diagnostics,” he said. Amanda Southcombe, General Manager of GSK NZ, said recent funding for Trelegy Ellipta, a ...

Dupixent (dupilumab) is a prescription drug that’s used to treat certain inflammatory conditions, such as atopic dermatitis (a type of eczema). Dupixent comes in a prefilled syringe or prefilled ...

GSK’s new asthma drug Relvar Ellipta has shown itself to be superior to existing treatments in a major real world trial, the Salford Lung Study (SLS). Developed with US respiratory specialist ...